AMY HENRY: Open Payments
NPI 1609653328 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 12 payments from 8 companies in 2025. Trend: 2023 $156 · 2024 $162 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $95 |
| ABBVIE INC. | 3 | $77 |
| Hologic Sales and Service, LLC | 1 | $31 |
| PFIZER INC. | 1 | $25 |
| Biogen, Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Organon LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Veozah, LILETTA, UBRELVY, MYOSURE TISSUE REMOVAL DEVICE, ABRYSVO, ZURZUVAE, JOURNAVX, NEXPLANON.
Industry payments across IA — which companies pay providers there.
